SABRINA TORRES: Open Payments
NPI 1487344677 · OAKLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,448 in 135 payments from 18 companies in 2025. Trend: 2023 $30 · 2024 $1,098 · 2025 $3,448
Food & beverage: $3,348Education: $100
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 43 | $1,154 |
| Incyte Corporation | 24 | $342 |
| ABBVIE INC. | 13 | $298 |
| Janssen Biotech, Inc. | 9 | $283 |
| UCB, Inc. | 9 | $261 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 8 | $172 |
| Regeneron Healthcare Solutions, Inc. | 2 | $160 |
| E.R. Squibb & Sons, L.L.C. | 1 | $123 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $116 |
| Almirall LLC | 4 | $111 |
Products named: Zoryve, OPZELURA, TREMFYA, Bimzelx, DUPIXENT, RINVOQ, SKYRIZI, JUBLIA.
Industry payments across CA — which companies pay providers there.
